Chris Ashton talks about his career and the recent merger of Argenta Discovery and Etiologics. Interview by Steve Carney.
Chris Ashton describes the driving force behind the merger of Argenta Discovery and Etiologics, as well as detailing the highlights and strategies of the company's new drug discovery programme.
Biotechnology↗